Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23903480 | 0.81 | MAPT (0.35) | MAPT | |
| SCHEMBL8144963 | 0.81 | MAPT (0.43) | MAPT | |
| SCHEMBL22036438 | 0.79 | MAPT (0.41) | MAPT | |
| SCHEMBL9288725 | 0.78 | TSHR (0.32) | — | |
| SCHEMBL4723082 | 0.77 | MAPT (0.39) | MAPT | |
| SCHEMBL6654058 | 0.76 | MAPT (0.36) | MAPTSLC29A1 | |
| SCHEMBL29581157 | 0.76 | CA12 (0.38) | MAPT | |
| SCHEMBL29581908 | 0.76 | CA12 (0.38) | MAPT | |
| SCHEMBL4763807 | 0.75 | MAPT (0.38) | MAPT | |
| SCHEMBL4446107 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9187460-B2 | Estrogen receptor modulators and uses thereof | SERAGON PHARMACEUTICALS, INC. (US) | 2015-11-17 | — | — | US | disclosed |
| US-20140364427-A1 | ESTROGEN RECEPTOR MODULATORS AND USES THEREOF | SERAGON PHARMACEUTICALS, INC. | 2014-12-11 | — | — | US | disclosed |
| EP-0088485-B2 | A PROCESS FOR THE REMOVAL OF HYDROGEN SULFIDE FROM GASEOUS MIXTURES WITH STRONGLY BASIC TERTIARY AMINO COMPOUNDS | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1989-09-13 | — | — | EP | disclosed |
| EP-0088485-B1 | A PROCESS FOR THE REMOVAL OF HYDROGEN SULFIDE FROM GASEOUS MIXTURES WITH STRONGLY BASIC TERTIARY AMINO COMPOUNDS | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1986-03-19 | — | — | EP | disclosed |
| EP-0088485-A1 | A process for the removal of hydrogen sulfide from gaseous mixtures with strongly basic tertiary amino compounds | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1983-09-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140364427-A1 | ESTROGEN RECEPTOR MODULATORS AND USES THEREOF | ESR2, ESRRG, GPER1 | MAPT 3601/4885SLC29A1 3883/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.